|
|
| Maladies Cardiovasculaires > Etude de marché sectorielle |
| Cardiac Rhythm Management Devices World Markets |
|
|
|
|
€ 800,00 |
Editeur
: |
TriMark |
Langue
: |
Anglais |
Date de publication : |
Mai 2004 |
Taille du document : |
188 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (1) |
|
|
|
| 1 pages | Mars 2006 | Anglais
|
|
|
| Main
focus: |
hospital,hospitals,heart failure,...
|
| Research
focus: |
market outlook,demand analysis,market definition, |
| Geographic
focus: |
usa,united kingdom |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Low and Light Outlook to 2006 Growth opportunities in diet and health food and drinks
150 pages | Février 2002 |
Taste continues to be seen as the number one driving force behind any product purchase, whilst fat content and calorie concerns are losing out to specific health benefits.
Low and Light Outlook |
953,48 €
|
| |
| |
Japan Pharmaceuticals 2004
12 pages | Décembre 2004 |
Snapdata's Japan Pharmaceuticals 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the Japanese pharmaceutical mar |
240,00 €
|
| |
| |
Stakeholder Insight: Dyslipidemia - Statins Dominate Treatment Pathway - For Now
204 pages | Octobre 2005 |
IntroductionDatamonitor estimates that there are 267m people in the seven major markets with total cholesterol >200mg/dL which is set to rise to 287m in 2015.
Despite this vast patient potential, l |
12 920,00 €
|
| |
| |
Fitness Equipment
90 pages | Juillet 2002 |
This report will enable you to:
·Analyse the size of the UK market for fitness equipment, in value terms, 1997-2006
·Quantify the size of the UK market for commercial cardiovascu |
635,00 €
|
| |
| |
Cholesterol and Other Cardiovascular Testing
244 pages | Août 2005 |
This report analyzes the worldwide markets for Cholesterol & Other Cardiovascular Testing in Millions of Units.
The specific product segments analyzed are Lipid Panel Test/Complete Lipid Profile, T |
2 308,00 €
|
| |
| |
Growth Strategies in Soft Drinks to 2006
146 pages | Octobre 2001 |
Traditional soft drinks markets, particularly carbonated, are experiencing low value growth in developed markets such as the US and Western Europe.
However, within these are fast moving niches, |
816,66 €
|
| |
| |
Hypertension and Diabetic Kidney Disease - Prevalence, current treatment and future options
71 pages | Octobre 2005 |
IntroductionThe increase in diabetic kidney disease is a worldwide problem.
Current treatment centers on antihypertensives inhibitors for the renin-angiotensin system and merely retards the decline |
3 230,00 €
|
| |
| |
Cardiac Defibrillators
257 pages | Août 2005 |
This report analyzes the worldwide markets for Cardiac Defibrillators in Units.
The specific product segments analyzed are Implantable/Internal Cardiac Defibrillator, and External Defibrillator.
2 699,00 €
|
|
| |
| |
PharmaVitae 2005: Novo Nordisk Global Analysis
128 pages | Octobre 2005 |
IntroductionThis analysis examines the current position and future outlook for Novo Nordisk in the ethical pharmaceutical sector.
The profile encompasses global company strategy, portfolio and pipe |
3 230,00 €
|
| |
| |
The eHealth Market in France: Assessing the Online Needs of Physicians and Consumers
25 pages | Juillet 2005 |
IntroductionThe eHealth market in France, driven by patients' and physicians' demands for online services, will provide opportunities for pharmaceutical companies to reach physicians and patients thro |
3 040,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Cardiac Rhythm Management Devices World Markets |
|
|
This report focuses on the U.S. market and worldwide sales and market trends for pacemakers, defibrillators, leads, and other related cardiac rhythm devices. The cardiac rhythm management markets are divided into the segments of: external defibrillators, implantable defibrillators, external pacemakers, implantable pacemakers, and defibrillator and pacemaker electrodes and leads heart failure specialty products.
|
|
Table of content available on demand
|
|
|
PPLSEN
|
|
|
|
|
